08/11/2015 // JusticeNewsFlash // (press release)
Illinois – An Illinois couple filed a lawsuit claiming the drug Zofran led to their baby suffering a serious birth defect. The Legal Examiner reported that the couple is seeking damages in excess of $75,000 in the lawsuit, which alleges drug maker GlaxoSmithKline failed to provide sufficient warnings about potential birth defects linked to the drug.
The complaint says that the mother took Zofran for the prevention of morning sickness while she was pregnant. The couple’s child born in 2006 was diagnosed with a condition called “Tetralogy of Fallot.” Due to the heart condition, the child has reportedly been required to undergo multiple medical procedures including heart surgery.
Zofran has been approved by the FDA for the prevention of nausea and vomiting in patients undergoing chemotherapy as well as those recovering from surgery. In 2012, GSK pled guilty to charges filed by the Department of Justice over “off-label” use drug promotion.
The recent case has been filed in the U.S. District Court for the Southern District of Illinois.